Red Blood Cell Transfusion clinical trials

Explore recruiting red blood cell transfusion clinical trials.

Recruiting red blood cell transfusion studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Red Blood Cell Transfusion trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA: a multicenter randomised, double blind placebo controlled trial. TRAAPrevia

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

ATLANTIS Protamine - Antagonization of heparin with protamine sulfate to reduce all neurologic ischemic and hemorrhagic events after transcatheter aortic valve implantation for aortic stenosis: the ATLANTIS Protamine study.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to Myelodysplastic Syndromes with del5q refractory/resistant/intolerant to Prior Treatments, Who Require Red Blood Cell Transfusion.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

France, Belgium, Germany, Italy, Bulgaria, Ireland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Study to Evaluate Efficacy and Safety of a Single Dose of Exa-cel in Subjects with Severe Sickle Cell Disease, βS/βC Genotype

Italy, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open label, multicenter roll-over extension program (REP) to characterize the long-term safety and tolerability of iptacopan (LNP023) in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) who have completed PNH Phase 2 and Phase 3 studies with iptacopan.

Germany, Italy, Czechia, France, Spain, Netherlands +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Red Blood Cell Transfusion trials by city

Red Blood Cell Transfusion in Toronto Red Blood Cell Transfusion in Vancouver Red Blood Cell Transfusion in Montreal Red Blood Cell Transfusion in Calgary Red Blood Cell Transfusion in Edmonton Red Blood Cell Transfusion in Ottawa Red Blood Cell Transfusion in Winnipeg Red Blood Cell Transfusion in Quebec City Red Blood Cell Transfusion in Hamilton Red Blood Cell Transfusion in Kitchener Red Blood Cell Transfusion in London Red Blood Cell Transfusion in Halifax Red Blood Cell Transfusion in New York Red Blood Cell Transfusion in Los Angeles Red Blood Cell Transfusion in Chicago Red Blood Cell Transfusion in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease